Glenmark Pharma Shares Rebound After Q3 Loss, Up 6% | Stock Market News
Glenmark Pharma stock recovers after posting Rs 330.8 crore net loss in Q3. Sales dip due to one-time India impact, forex loss, inflation. Revenue excluding one-time impact up 9% YoY. Gross margins down 750 bps YoY to 58.8%.
Written By: Zee Business Video Team